TY  - JOUR
AU  - Carmona, Andres
AU  - Agüera, Maria L
AU  - Luna-Ruiz, Carlos
AU  - Buendia, Paula
AU  - Calleros, Laura
AU  - Garcia-Jerez, Andrea
AU  - Rodriguez-Puyol, Manuel
AU  - Arias, Manuel
AU  - Arias-Guillen, Marta
AU  - de Arriba, Gabriel
AU  - Ballarin, Jose
AU  - Bernis, Carmen
AU  - Fernandez, Elvira
AU  - Garcia-Rebollo, Sagrario
AU  - Mancha, Javier
AU  - Del Peso, Gloria
AU  - Perez, Estefania
AU  - Poch, Esteban
AU  - Portoles, Jose M
AU  - Rodriguez-Puyol, Diego
AU  - Sanchez-Villanueva, Rafael
AU  - Sarro, Felipe
AU  - Torres, Armando
AU  - Martin-Malo, Alejandro
AU  - Aljama, Pedro
AU  - Ramirez, Rafael
AU  - Carracedo, Julia
PY  - 2017
DO  - 10.1152/ajprenal.00013.2016
UR  - http://hdl.handle.net/10668/10764
T2  - American journal of physiology. Renal physiology
AB  - Patients with Stage 5 chronic kidney disease who are on hemodialysis (HD) remain in a chronic inflammatory state, characterized by the accumulation of uremic toxins that induce endothelial damage and cardiovascular disease (CVD). Our aim was to...
LA  - en
PB  - American Physiological Society
KW  - Cardiovascular disease
KW  - Chronic kidney disease
KW  - Diabetes mellitus
KW  - Inflammation, hemodialysis
KW  - Microvesicles
KW  - Aged
KW  - Angiopoietin-1
KW  - Angiopoietin-2
KW  - Biomarkers
KW  - Case-control studies
KW  - Cell-derived microparticles
KW  - Diabetic nephropathies
KW  - Disease progression
KW  - Endothelial cells
KW  - Female
KW  - Humans
KW  - Inflammation mediators
KW  - Kaplan-meier estimate
KW  - Male
KW  - Middle aged
KW  - Monocytes
KW  - Predictive value of tests
KW  - Prevalence
KW  - Renal dialysis
KW  - Renal insufficiency, chronic
KW  - Spain
KW  - Time factors
KW  - Treatment outcome
TI  - Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.
TY  - research article
VL  - 312
ER  -